XpresSpa Group’s New Travel Health & Wellness Brand Treat™ Launches its First Brick and Mortar Location Now Open at John F. Kennedy International Airport’s Terminal 4
“In this pandemic world, people are now prioritizing health and wellness, especially when traveling,” said Doug Satzman, XpresSpa Group CEO. “This first-of-it’s-kind suite of travel health and wellness services is leading a new era in wellness travel - whether you need a test, want to work out, seek healthcare on-the-go, or just escape from the stressors of travel, Treat will be an invaluable set of resources as traveler needs continue to evolve.”
Satzman continued, “Treat’s membership, via the mobile app, provides unlimited access to on-demand virtual care and provides a health wallet, where one can upload, store and control medical records in a HIPPA-secure environment. Use the app to schedule appointments at Treat in-airport wellness centers starting at JFK T4 today for everything from Covid-19 Rapid PCR testing and anxiety care to reserving private rooms for yoga or meditation sessions. In conjunction with the website, Treat.com provides the latest COVID travel requirements, delivers original content, tips and offers a variety of products that make traveling the world with confidence easier.”
“We are very pleased to partner with
The launch of Treat’s first brick and mortar location (Phase Three) is the final major milestone in the three-phase plan to provide travelers with integrated health and wellness care at the tip of their fingers through Treat. Combined with the June launch of treat.com (Phase One) and, Treat’s mobile app (Phase Two) launched in August, Treat’s first physical location, rounds out a 360 degree offering for members and travelers.
About
To learn more about Treat, visit: www.Treat.com.
To learn more about XpresCheck, visit: www.XpresCheck.com.
To learn more about
Twitter: @Treat_Care and Instagram: @treat_care
Twitter: @xprescheck and Instagram: @realxprescheck
Twitter @XpresSpa and Instagram: @XpresSpa
Forward-Looking Statements
This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. In particular, these statements include, without limitation, statements about our expectations relating to our new XpresCheck™ concept, being able to expand testing to other communicable diseases as well as administer vaccinations for the seasonal flu, our positioning to be part of the national rollout of various COVID-19 vaccinations as they become available, the degree to which our public testing model assists passengers meet testing requirements in select states and countries, our ability to identify and gain access to the latest and best COVID-19 testing methodologies and equipment, and our ability to further expand our initial sites and our overall ability to manage the regulatory challenges associated with this business line. Forward-looking statements relating to expectations about future results or events are based upon information available to
Media:
JFPRMEDIAGROUP
Julie@jfprmedia.com
(312) 385-0098
Investor Relations:
ICR
ir@xpresspagroup.com
(203) 682-8253
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/43e8c545-504a-48b2-a8cb-39f23d9d121a
Source: XpresSpa Group, Inc.